glp-1 vision loss ema recommendation november 2025 finds no link between receptor agonists and suicidal thoughts What is the pipeline for

So far, HIMS is down about 60% from its peak last July, reflecting a shift in how investors price growth quality and compliance durability

A., Wang, Z

Weight loss can be a challenge for many of us

GLP-1 and Dexcom G7: managing diabetes better together GLP-1 meet your perfect match

Aug 14: In what is expected to become a multibillion-dollar blockbuster, Pfizers BCMAxCD3 bispecific antibody Elrexfio (elranatamab-bcmm) has secured an FDA accelerated approval as another off-the-shelf treatment option for patients with relapsed or refractory multiple myeloma (RRMM) who have received at least four prior lines of therapy

But compressed eating windows make hitting 100+ grams of protein harder, not easier